Publication: Therapeutic Drug Monitoring in Children and Adolescents: Findings on Fluoxetine from the TDM-VIGIL Trial
Therapeutic Drug Monitoring in Children and Adolescents: Findings on Fluoxetine from the TDM-VIGIL Trial
Date
Date
Date
Citations
Frey, M., Smigielski, L., Tini, E., Fekete, S., Fleischhaker, C., Wewetzer, C., Karwautz, A., Correll, C. U., Gerlach, M., Taurines, R., Plener, P. L., Malzahn, U., Kornbichler, S., Weninger, L., Brockhaus, M., Reuter-Dang, S.-Y., Reitzle, K., Rock, H., Imgart, H., … Egberts, K. M. (2023). Therapeutic Drug Monitoring in Children and Adolescents: Findings on Fluoxetine from the TDM-VIGIL Trial. Pharmaceutics, 15(9), 2202. https://doi.org/10.3390/pharmaceutics15092202
Abstract
Abstract
Abstract
Fluoxetine is the recommended first-line antidepressant in many therapeutic guidelines for children and adolescents. However, little is known about the relationships between drug dose and serum level as well as the therapeutic serum reference range in this age group. Within a large naturalistic observational prospective multicenter clinical trial (“TDM-VIGIL”), a transdiagnostic sample of children and adolescents (n = 138; mean age, 15; range, 7–18 years; 24.6% males) was treated with fluoxetine (10–40 mg/day). Analyses of both the la
Metrics
Downloads
Views
Additional indexing
Creators (Authors)
Volume
Volume
Volume
Number
Number
Number
Page range/Item number
Page range/Item number
Page range/Item number
Item Type
Item Type
Item Type
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Keywords
Language
Language
Language
Publication date
Publication date
Publication date
Date available
Date available
Date available
ISSN or e-ISSN
ISSN or e-ISSN
ISSN or e-ISSN
OA Status
OA Status
OA Status
Free Access at
Free Access at
Free Access at
Publisher DOI
Metrics
Downloads
Views
Citations
Frey, M., Smigielski, L., Tini, E., Fekete, S., Fleischhaker, C., Wewetzer, C., Karwautz, A., Correll, C. U., Gerlach, M., Taurines, R., Plener, P. L., Malzahn, U., Kornbichler, S., Weninger, L., Brockhaus, M., Reuter-Dang, S.-Y., Reitzle, K., Rock, H., Imgart, H., … Egberts, K. M. (2023). Therapeutic Drug Monitoring in Children and Adolescents: Findings on Fluoxetine from the TDM-VIGIL Trial. Pharmaceutics, 15(9), 2202. https://doi.org/10.3390/pharmaceutics15092202